口腔癌中的肿瘤标志物：综述
Tumor markers in oral cancer: A review.
作者信息
Rajguru Jagadish Prasad, Mouneshkumar C D, Radhakrishnan Indu Cherangapadath, Negi Bhupender Singh, Maya Deepthi, Hajibabaei Sahar, Rana Vivek
机构信息
Department of Oral and Maxillofacial Pathology, Hi-Tech Dental College and Hospital, Bhubaneswar, Odisha, India.
Department of Oral and Maxillofacial Surgery, School of Dental Sciences, Krishna Institute of Medical Sciences, Deemed to be University, Karad, Maharashtra, India.
出版信息
J Family Med Prim Care. 2020 Feb 28;9(2):492-496. doi: 10.4103/jfmpc.jfmpc_1036_19. eCollection 2020 Feb.
Abstract
Tumor markers are the substances produced in response to the presence of cancer either by the body itself or by the cancer cells. These markers mostly are the proteins that are produced at a greater rate by the cancer cells. Increased levels of these substances can be detected in urine, blood, or body tissues of the patients with certain types of cancer. These markers are useful in differentiating primary or secondary tumors. In few noncancerous conditions, these markers are often found to be elevated. For these reasons, the knowledge regarding these biomarkers has increased tremendously. This article classifies the different types of tumor markers and implicates their role in some diseases.
摘要
肿瘤标志物是机体自身或癌细胞针对癌症的存在而产生的物质。这些标志物大多是癌细胞以更高速率产生的蛋白质。在某些类型癌症患者的尿液、血液或身体组织中可检测到这些物质水平升高。这些标志物有助于鉴别原发性或继发性肿瘤。在少数非癌性疾病中，也常发现这些标志物升高。基于这些原因，关于这些生物标志物的知识有了极大增长。本文对不同类型的肿瘤标志物进行了分类，并阐述了它们在某些疾病中的作用。
相似文献
1
Tumor markers in oral cancer: A review.口腔癌中的肿瘤标志物：综述
J Family Med Prim Care. 2020 Feb 28;9(2):492-496. doi: 10.4103/jfmpc.jfmpc_1036_19. eCollection 2020 Feb.
2
Tumor markers: A diagnostic tool.肿瘤标志物：一种诊断工具。
Natl J Maxillofac Surg. 2016 Jan-Jun;7(1):17-20. doi: 10.4103/0975-5950.196135.
3
The effects of some tumor markers on human erythrocyte (HCA-I and HCA-II), bovine erythrocyte (BCA) and bovine lung (CA-IV) carbonic anhydrase enzyme activities in vitro.某些肿瘤标志物对人红细胞（HCA-I和HCA-II）、牛红细胞（BCA）以及牛肺（CA-IV）碳酸酐酶体外酶活性的影响。
Bratisl Lek Listy. 2015;116(5):330-3. doi: 10.4149/bll_2015_062.
4
[The present and the future of tumor markers].[肿瘤标志物的现状与未来]
Nihon Sanka Fujinka Gakkai Zasshi. 1991 Aug;43(8):883-9.
5
Secretome profiling of primary cells reveals that THBS2 is a salivary biomarker of oral cavity squamous cell carcinoma.原代细胞的分泌蛋白质组分析表明，血小板反应蛋白2是口腔鳞状细胞癌的唾液生物标志物。
J Proteome Res. 2014 Nov 7;13(11):4796-807. doi: 10.1021/pr500038k. Epub 2014 Apr 16.
6
Integrative genomic data mining for discovery of potential blood-borne biomarkers for early diagnosis of cancer.整合基因组数据挖掘以发现用于癌症早期诊断的潜在血源生物标志物。
PLoS One. 2008;3(11):e3661. doi: 10.1371/journal.pone.0003661. Epub 2008 Nov 6.
7
Clinical use of tumor markers in childhood malignancies.肿瘤标志物在儿童恶性肿瘤中的临床应用。
Ann Med. 2002;34(5):316-23. doi: 10.1080/078538902320772070.
8
Telomerase expression in noncancerous bronchial epithelia is a possible marker of early development of lung cancer.非癌性支气管上皮中的端粒酶表达可能是肺癌早期发展的一个标志物。
Cancer Res. 2005 Nov 1;65(21):9623-7. doi: 10.1158/0008-5472.CAN-05-0976.
9
The monitoring role of plasma CEA alone and in association with other tumor markers in colorectal and mammary carcinoma.血浆癌胚抗原单独及与其他肿瘤标志物联合在结直肠癌和乳腺癌中的监测作用。
Cancer. 1978 Sep;42(3 Suppl):1448-51. doi: 10.1002/1097-0142(197809)42:3+<1448::aid-cncr2820420812>3.0.co;2-w.
10
Circulating tumor markers and nuclear medicine imaging modalities: breast, prostate and ovarian cancer.循环肿瘤标志物与核医学成像方式：乳腺癌、前列腺癌和卵巢癌
Q J Nucl Med. 2002 Jun;46(2):88-104.
引用本文的文献
1
Comparative Analysis of Salivary Tumor Marker CA-125 Among Oral Squamous Cell Carcinoma Patients and Healthy Individuals.口腔鳞状细胞癌患者与健康个体唾液肿瘤标志物CA-125的对比分析
Dent J (Basel). 2025 Apr 29;13(5):194. doi: 10.3390/dj13050194.
2
Does a Well-Differentiated Oral Squamous Cell Carcinoma Always Behave Well? A Case Series.高分化口腔鳞状细胞癌的行为总是良好吗？病例系列报道
J Microsc Ultrastruct. 2022 Dec 1;13(1):42-48. doi: 10.4103/jmau.jmau_35_22. eCollection 2025 Jan-Mar.
3
The Use of Diagnostic Tumor Markers in Detecting Tobacco- and Betel Quid-Induced Oral Squamous Cell Carcinoma: A Scoping Review of Empirical Evidence.诊断性肿瘤标志物在检测烟草和槟榔诱导的口腔鳞状细胞癌中的应用：实证证据的范围综述
Health Sci Rep. 2025 Apr 18;8(4):e70650. doi: 10.1002/hsr2.70650. eCollection 2025 Apr.
4
Pathogenomic fingerprinting to identify associations between tumor morphology and epigenetic states.通过病原体基因组指纹识别肿瘤形态与表观遗传状态之间的关联。
Eur J Cancer. 2025 May 15;221:115429. doi: 10.1016/j.ejca.2025.115429. Epub 2025 Apr 14.
5
Quantum dots: The trailblazers of early detection.量子点：早期检测的开拓者。
J Oral Maxillofac Pathol. 2024 Jan-Mar;28(1):100-105. doi: 10.4103/jomfp.jomfp_377_23. Epub 2024 Apr 15.
6
Salivary Neutrophil-to-Lymphocyte Ratio as a Prognostic Predictor of Oral Premalignant and Malignant Disorders: A Prospective Study.唾液中性粒细胞与淋巴细胞比值作为口腔癌前病变和恶性病变的预后预测指标：一项前瞻性研究。
Cureus. 2024 Mar 16;16(3):e56273. doi: 10.7759/cureus.56273. eCollection 2024 Mar.
7
Immunohistochemical expression of E-Cadherin and Cyclin D1 in different grades of oral squamous cell carcinoma.E-钙黏蛋白和细胞周期蛋白D1在不同分级口腔鳞状细胞癌中的免疫组化表达
J Oral Maxillofac Pathol. 2023 Jul-Sep;27(3):476-480. doi: 10.4103/jomfp.jomfp_257_23. Epub 2023 Sep 12.
8
Expression sites of immunohistochemistry markers in oral diseases - A scoping review.口腔疾病中免疫组织化学标志物的表达部位——一项范围综述
J Oral Maxillofac Pathol. 2022 Oct-Dec;26(4):524-533. doi: 10.4103/jomfp.jomfp_364_22. Epub 2022 Dec 22.
9
Exosomal microRNAs (exoMIRs): micromolecules with macro impact in oral cancer.外泌体微小RNA（外泌体miRNA）：对口腔癌具有重大影响的微小分子。
3 Biotech. 2022 Jul;12(7):155. doi: 10.1007/s13205-022-03217-z. Epub 2022 Jun 26.
10
Serum ceruloplasmin as cancer marker in oral pre-cancers and cancers.血清铜蓝蛋白作为口腔癌前病变和癌症的肿瘤标志物。
J Carcinog. 2021 Sep 30;20:15. doi: 10.4103/jcar.jcar_10_21. eCollection 2021.
本文引用的文献
1
Diagnostic Tumor Markers in Head and Neck Squamous Cell Carcinoma (HNSCC) in the Clinical Setting.临床环境中头颈部鳞状细胞癌（HNSCC）的诊断性肿瘤标志物
Front Oncol. 2019 Aug 29;9:827. doi: 10.3389/fonc.2019.00827. eCollection 2019.
2
Molecular Biomarkers Related to Oral Carcinoma: Clinical Trial Outcome Evaluation in a Literature Review.口腔癌相关分子标志物的文献回顾：临床试验结局评价。
Dis Markers. 2019 Mar 25;2019:8040361. doi: 10.1155/2019/8040361. eCollection 2019.
3
Invasion-Related Factors as Potential Diagnostic and Therapeutic Targets in Oral Squamous Cell Carcinoma-A Review.侵袭相关因素作为口腔鳞状细胞癌潜在的诊断和治疗靶点——综述
Int J Mol Sci. 2018 May 14;19(5):1462. doi: 10.3390/ijms19051462.
4
Tumor markers: A diagnostic tool.肿瘤标志物：一种诊断工具。
Natl J Maxillofac Surg. 2016 Jan-Jun;7(1):17-20. doi: 10.4103/0975-5950.196135.
5
Tumour markers: An overview.肿瘤标志物：概述
Indian J Clin Biochem. 2007 Sep;22(2):17-31. doi: 10.1007/BF02913308.
6
Nucleolar organizer regions in a chronic stress and oral cancer model.慢性应激与口腔癌模型中的核仁组织区
Oncol Lett. 2012 Mar;3(3):541-544. doi: 10.3892/ol.2011.514. Epub 2011 Dec 6.
7
Carcinoembryonic antigen (CEA)-based cancer vaccines: recent patents and antitumor effects from experimental models to clinical trials.基于癌胚抗原（CEA）的癌症疫苗：从实验模型到临床试验的最新专利和抗肿瘤效果。
Recent Pat Anticancer Drug Discov. 2012 Sep;7(3):265-96. doi: 10.2174/157489212801820020.
8
Tumor markers in clinical practice: a review focusing on common solid cancers.临床实践中的肿瘤标志物：重点关注常见实体瘤的综述。
Med Princ Pract. 2013;22(1):4-11. doi: 10.1159/000338393. Epub 2012 May 15.
9
p53, Stem Cells, and Reprogramming: Tumor Suppression beyond Guarding the Genome.p53、干细胞与重编程：超越基因组守护的肿瘤抑制
Genes Cancer. 2011 Apr;2(4):404-19. doi: 10.1177/1947601911410224.
10
The effects of growth inhibitory peptide on follicular thyroid cancer cell growth, migration, and invasion.生长抑制肽对甲状腺滤泡癌细胞生长、迁移和侵袭的影响。
Tumori. 2010 May-Jun;96(3):448-51. doi: 10.1177/030089161009600312.
Zotero 插件